產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-INPP5F抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-INPP5F抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-INPP5F
Cat. Number:
Anti-INPP5F抗體KL-11256R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The inositol polyphosphate 5-phosphatases selectively remove the phosphate from the 5-position of various phosphatidylinositols, Anti-INPP5F抗體which generate second messengers in response to extracellular signals. OCRL1 is a type II 5-phosphatase that is mutated in the oculocerebrorenal syndrome of Lowe (OCRL). OCRL is a rare X-linked disorder that is characterized in part by congenital cataracts, mental retardation, muscular hypotonia, and renal tubular dysfunction. OCRL1 has a high affinity for phosphatidylinositol 4,5-bisphosphate as well as inositol 1,4,5-trisphosphate, and inositol 1,3,4,5-tetrakisphosphate as substrates. OCRL1 is localized to the Golgi complex and is thought to be part of the trans-Golgi network (TGN), which suggests that OCRL1 plays a role in protein sorting and trafficking within the cell.
Also known as:
Inositol polyphosphate 5 phosphatase OCRL 1; Inositol polyphosphate 5 phosphatase OCRL1; Inositol polyphosphate 5-phosphatase Anti-INPP5F抗體OCRL-1; INPP5F; LOCR; Lowe oculocerebrorenal syndrome protein; NPHL2; OCRL; OCRL_HUMAN; OCRL1; EC 3.1.3.36; Oculocerebrorenal syndrome of Lowe; Phosphatidylinositol polyphosphate 5 phosphatase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, GPV, Monkey, ,mk.
●
Immunogen: KLH conjugated synthetic peptide derived from human INPP5F.
●
Predicted Molecular Weight: 104kDa.Anti-INPP5F抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-INPP5F抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl309Bo01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Ca01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Hu01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Mu01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Po01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Ra01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl310Bo01 載脂蛋白H(APOH)多克隆抗體 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Ca01 載脂蛋白H(APOH)多克隆抗體 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Hu01 載脂蛋白H(APOH)多克隆抗體 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Mu01 載脂蛋白H(APOH)多克隆抗體 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Ra01 載脂蛋白H(APOH)多克隆抗體 Polyclonal Antibody to Apolipoprotein H (APOH)
kl312Hu01 半乳糖凝集素12(GAL12)多克隆抗體 Polyclonal Antibody to Galectin 12 (GAL12)
kl312Mu01 半乳糖凝集素12(GAL12)多克隆抗體 Polyclonal Antibody to Galectin 12 (GAL12)
kl314Cp01 半乳糖凝集素14(GAL14)多克隆抗體 Polyclonal Antibody to Galectin 14 (GAL14)
